“Sparsentan: Sparsentan- A novel, non- immunosuppressive, dual action angiotensin II and endothelin A receptor antagonist -A new hope for glomerular disease”, J Shaheed Suhrawardy Med Coll, vol. 14, no. 2, pp. 58–62, May 2024, doi: 10.3329/jssmc.v14i2.73180.